111 (YI) Revenue & Revenue Breakdown
111 Revenue Highlights
Latest Revenue (Y)
$14.95B
Latest Revenue (Q)
$3.53B
Main Segment (Y)
Product
111 Revenue by Period
111 Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $14.95B | 10.59% |
| 2022-12-31 | $13.52B | 8.78% |
| 2021-12-31 | $12.43B | 51.48% |
| 2020-12-31 | $8.20B | 107.57% |
| 2019-12-31 | $3.95B | 121.28% |
| 2018-12-31 | $1.79B | 86.14% |
| 2017-12-31 | $959.49M | 9.80% |
| 2016-12-31 | $873.84M | - |
111 generated $14.95B in revenue during NA 2023, up 10.59% compared to the previous quarter, and up 836.98% compared to the same period a year ago.
111 Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $3.53B | -14.12% |
| 2023-12-31 | $4.11B | 12.10% |
| 2023-09-30 | $3.67B | 5.40% |
| 2023-06-30 | $3.48B | -5.93% |
| 2023-03-31 | $3.70B | -10.88% |
| 2022-12-31 | $4.15B | 23.88% |
| 2022-09-30 | $3.35B | 10.26% |
| 2022-06-30 | $3.04B | 1.83% |
| 2022-03-31 | $2.98B | -13.82% |
| 2021-12-31 | $3.46B | 3.43% |
| 2021-09-30 | $3.35B | 10.65% |
| 2021-06-30 | $3.02B | 16.55% |
| 2021-03-31 | $2.59B | -1.82% |
| 2020-12-31 | $2.64B | 11.86% |
| 2020-09-30 | $2.36B | 45.68% |
| 2020-06-30 | $1.62B | 2.93% |
| 2020-03-31 | $1.58B | 16.90% |
| 2019-12-31 | $1.35B | 21.38% |
| 2019-09-30 | $1.11B | 32.49% |
| 2019-06-30 | $838.16M | 27.85% |
| 2019-03-31 | $655.60M | 17.62% |
| 2018-12-31 | $557.40M | 12.01% |
| 2018-09-30 | $497.62M | 24.18% |
| 2018-06-30 | $400.74M | 21.36% |
| 2018-03-31 | $330.20M | 19.71% |
| 2017-12-31 | $275.83M | 11.02% |
| 2017-09-30 | $248.44M | - |
111 generated $3.53B in revenue during Q1 2024, up -14.12% compared to the previous quarter, and up 85.06% compared to the same period a year ago.
111 Revenue Breakdown
111 Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Drugs | $13.88B | $11.68B | $7.40B | $3.60B | - |
| Service, Other | $35.95M | $44.78M | - | - | - |
| Service | $106.22M | $94.20M | $46.48M | $22.36M | - |
| Product | $14.84B | $12.33B | $8.16B | $3.93B | - |
| Other Products | $170.23M | $46.53M | $20.35M | - | - |
| Nutritional Supplements | $631.12M | $559.24M | $245.64M | - | - |
| Medical Supplies And Devices | $157.50M | $149.05M | $50.18M | - | - |
| MP Service | $70.27M | $68.48M | $52.31M | - | - |
| Contact lenses. | - | - | $38.00K | - | - |
| Medical supplies and devices | - | - | $124.92M | - | - |
| Nutritional supplements | - | - | $442.50M | - | - |
| Other Services | - | - | $41.89M | - | - |
| Other products. | - | - | $83.14M | - | - |
| Service Other | - | - | - | $15.95M | $5.12M |
| Mp Service | - | - | - | $30.53M | $17.24M |
| Contact Lenses | - | - | - | $3.42M | $18.11M |
111's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (49.64%), Drugs (46.44%), Nutritional Supplements (2.11%), Other Products (0.57%), Medical Supplies And Devices (0.53%), Service (0.36%), MP Service (0.24%), and Service, Other (0.12%).
111 Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| WBA | Walgreens Boots Alliance | $268.79B | $36.35B |
| RAD | Rite Aid | $24.09B | $5.65B |
| YI | 111 | $14.95B | $3.53B |
| HITI | High Tide | $487.67M | $124.26M |
| PETS | PetMed Express | $281.06M | $117.93M |
| CJJD | China Jo-Jo Drugstores | $148.81M | $78.57M |
| MDVL | MedAvail | $43.11M | $405.00K |
| LFLY | Leafly | $42.25M | $9.05M |
| BIMI | BIMI Medical | $11.83M | $2.52M |
| MEDS | Scienture | $8.27M | $18.70K |
YI Revenue FAQ
What is 111’s yearly revenue?
111's yearly revenue for 2023 was $14.95B, representing an increase of 10.59% compared to 2022. The company's yearly revenue for 2022 was $13.52B, representing an increase of 8.78% compared to 2021. YI's yearly revenue for 2021 was $12.43B, representing an increase of 51.48% compared to 2020.
What is 111’s quarterly revenue?
111's quarterly revenue for Q1 2024 was $3.53B, a -14.12% decrease from the previous quarter (Q4 2023), and a -4.55% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.11B, a 12.10% increase from the previous quarter (Q3 2023), and a -0.96% decrease year-over-year (Q4 2022). YI's quarterly revenue for Q3 2023 was $3.67B, a 5.40% increase from the previous quarter (Q2 2023), and a 9.45% increase year-over-year (Q3 2022).
What is 111’s revenue growth rate?
111's revenue growth rate for the last 3 years (2021-2023) was 20.30%, and for the last 5 years (2019-2023) was 278.24%.
What are 111’s revenue streams?
111's revenue streams in c 23 are Drugs, Service, Other, Service, Product, Other Products, Nutritional Supplements, Medical Supplies And Devices, and MP Service. Drugs generated $13.88B in revenue, accounting 46.44% of the company's total revenue, up 18.85% year-over-year. Service, Other generated $35.95M in revenue, accounting 0.12% of the company's total revenue, down -19.73% year-over-year. Service generated $106.22M in revenue, accounting 0.36% of the company's total revenue, up 12.76% year-over-year. Product generated $14.84B in revenue, accounting 49.64% of the company's total revenue, up 20.36% year-over-year. Other Products generated $170.23M in revenue, accounting 0.57% of the company's total revenue, up 265.86% year-over-year. Nutritional Supplements generated $631.12M in revenue, accounting 2.11% of the company's total revenue, up 12.85% year-over-year. Medical Supplies And Devices generated $157.5M in revenue, accounting 0.53% of the company's total revenue, up 5.67% year-over-year. MP Service generated $70.27M in revenue, accounting 0.24% of the company's total revenue, up 2.62% year-over-year.
What is 111’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of 111 was Product. This segment made a revenue of $14.84B, representing 49.64% of the company's total revenue.